Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2023-03-01 00:00:00 ET · period of report 2023-02-28 · accession 0001127602-23-007927 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-01 | 2023-02-28 | LXRX | MAIN ALAN J | EVP, Innov, Chem Sciences | F - Tax | $2.17 | -20.9K | 212.6K | -9% | -$45.5K |
| DM | 2023-03-01 | 2023-02-28 | LXRX | MAIN ALAN J | EVP, Innov, Chem Sciences | M - OptEx | — | +57.9K | 233.5K | +33% | — |
| DM | 2023-03-01 | 2023-02-28 | LXRX | MAIN ALAN J | EVP, Innov, Chem Sciences | M - OptEx | — | -57.9K | 51.3K | -53% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | F | D | 20,946 | $2.17 | 212,586 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-28 | M | A | 8,976 | — | 207,865 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 3 | Common | Common Stock | 2023-02-28 | M | A | 23,300 | — | 198,889 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 4 | Common | Common Stock | 2023-02-28 | M | A | 25,667 | — | 233,532 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 5 | Derivative | Restricted Stock Units | 2023-02-28 | M | D | 23,300 | — | 0 | D | — · — to — | 23,300 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 6 | Derivative | Restricted Stock Units | 2023-02-28 | M | D | 8,976 | — | 8,977 | D | — · — to — | 8,976 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 7 | Derivative | Restricted Stock Units | 2023-02-28 | M | D | 25,667 | — | 51,333 | D | — · — to — | 25,667 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |